/PRNewswire/ Berkshire Biomedical Corporation ("Berkshire" or the "Company"), focused on developing its proprietary drug dispensing technology to enhance.
SAN DIEGO (BUSINESS WIRE) Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary computational drug discovery platform, announced today that it has selected SB-0110 after extensive preclinical studies as its lead clinical candidate for Parkinson’s disease a.
BOSTON, April 05, 2023 TransCode Therapeutics, Inc. , the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has been. | April 5, 2023
/PRNewswire/ Berkshire Biomedical Corporation ("Berkshire" or the "Company"), focused on developing its proprietary drug dispensing technology to enhance.